Skip links

Regulatory briefing

Michigan says yes, North Dakota says no to recreational cannabis

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in...

Cannabis in the UK now medically legal – up to a point

Written by Freddie Dawson || 1st November 2018 || Regulatory briefing |

Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
Medical cannabis products are now legal in the UK – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions ...

Canada learning early lessons in enforcement after legalisation

Written by Freddie Dawson || 26th October 2018 || Regulatory briefing |

Canada
North America
Regulatory briefing
The legalisation of Cannabis farming and commercialisation that became effective last week has created a new dynamic legal market for high- and low-THC cannabis strains and by-products in Canada, such as food products or e-liquids. One week after the...

CBD medicines for animals will need UK government approval

Written by Barnaby Page || 26th September 2018 || Regulatory briefing |

EU
Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...

Experiments on mice suggest you can’t get addicted to CBD

Written by Marc Beishon || 23rd August 2018 || Regulatory briefing |

Europe
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities ...

French warnings over ‘stores likely to be selling illegal products’

Written by David Palacios || 17th August 2018 || Regulatory briefing |

Europe
France
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation ...

US authorities call into question the legality of CBD

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness ...